Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic DrugsGBI ResearchFebruary 1, 2012 75 Pages - SKU: XGBR6784724 |
Enter a term to search inside this document.
|
Use the same search language as you do when searching for reports Search terms are implicitly ORed together. This means that a search for Bottled Water is equivalent to a search for Bottled OR Water. In this scenario, only sections that contain either the word 'Bottled' or the word 'Water' will have ""Keywords in Context"" results. To find sections that contain all of the search terms, separate the search terms with 'AND' ex Bottled AND Water |
Related Markets
Pricing Reports
- Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure
- The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
- Pharmaceutical Pricing Strategies – Changing Approaches to Meet Challenging Times
